About
NRDL+ Executive Debrief helps senior life sciences decision-makers turn health policy shifts into clear commercial strategies for China.
- Newsletter: Join top life sciences leaders, insurance experts, and leading university researchers by subscribing to our free newsletter.
- China Health Policy Executive Briefing: A quarterly health policy intelligence service, purpose-built for senior life sciences leaders shaping portfolio, pricing, and go-to-market strategies in China’s fast-evolving access and payment environment. We surface what matters—and translate it into client-specific insights. Each engagement also includes a team subscription to Access360, our platform for real-time policy updates and capability building through deep-dive articles and executive courses.
- Bespoke Engagement: We deliver tailored solutions to help life sciences firms apply policy insights to product-level decisions, access strategies, and broader commercial planning for the Chinese market.
NRDL+ Executive Debrief is powered by bizi LLC, a New Jersey-based consultancy with over a decade of experience helping life sciences leaders navigate pricing, reimbursement, and access challenges across global and local markets.
People
Kelly Ke
Founder, bizi LLC | Author, NRDL+ Executive Debrief
Kelly spent ten years as an award-winning senior advisor in Deloitte US’s life sciences practice before founding bizi, a firm that has helped life sciences companies navigate pricing, reimbursement, and access challenges locally and globally for over a decade.
She operates at the intersection of health policy, commercial strategy, and execution—helping global leaders translate China’s evolving policy landscape into market-informed decisions.
Kelly is also the author of the NRDL+ Executive Debrief, a widely followed newsletter on China market access, with readers from over two-thirds of the world’s top 30 pharmaceutical companies, as well as leading biotechs, insurers, hospital groups, and academic institutions including Harvard, USC, UCLA, and Northwestern Kellogg.
Originally from Beijing, Kelly holds master’s degrees from the University of Southern California and the University of Utah, as well as a postgraduate certificate in International Health Technology Assessment (HTA) and Reimbursement from the University of Sheffield.